Literature DB >> 25647261

MiR-32 induces cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting PTEN.

Shi-Yan Yan1, Mei-Mei Chen, Guang-Ming Li, Yu-Qin Wang, Jian-Gao Fan.   

Abstract

MicroRNAs (miRNAs) regulate gene expression by inhibiting translation of target messenger RNAs (mRNAs) through pairing with miRNA recognition elements (MREs), usually in 3'-UTRs. miRNAs are involved in the pathogenesis of several types of cancers. Specifically, microRNA-32 (miR-32) is overexpressed in colorectal carcinoma, wherein accumulating evidence indicates that it functions as an oncogene. However, the function of miR-32 in hepatocellular carcinoma (HCC) has not been totally elucidated. In the present study, we found the expression of miR-32 was up-regulated in HCC tissue and cell lines, inversely the expression of phosphatase and tensin homolog (PTEN) decreased. Besides, miRNA-32 down-regulates PTEN through binding to 3'-UTR of PTEN mRNA from luciferase reporter assay, and the expression level of miR-32 could affect the proliferation, migration, and invasion of liver cancer cell lines via PTEN/Akt signaling pathway. Down-expression of PTEN could significantly attenuate the inhibitory effects of knockdown miR-32 on the proliferation, migration, and invasion of liver cancer cells, suggesting that miR-32 could be a potential target for HCC treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25647261     DOI: 10.1007/s13277-015-3124-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

1.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

Review 2.  MicroRNAs: small RNAs with a big role in gene regulation.

Authors:  Lin He; Gregory J Hannon
Journal:  Nat Rev Genet       Date:  2004-07       Impact factor: 53.242

3.  The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.

Authors:  Fang Zheng; Yi-Ji Liao; Mu-Yan Cai; Yan-Hui Liu; Tian-Hao Liu; Shu-Peng Chen; Xiu-Wu Bian; Xin-Yuan Guan; Marie C Lin; Yi-Xin Zeng; Hsiang-Fu Kung; Dan Xie
Journal:  Gut       Date:  2011-06-14       Impact factor: 23.059

4.  Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.

Authors:  Qing Xie; Xiangmei Chen; Fengmin Lu; Ting Zhang; Meili Hao; Yongfeng Wang; Jingmin Zhao; Malcolm A McCrae; Hui Zhuang
Journal:  Cancer       Date:  2011-10-11       Impact factor: 6.860

5.  MicroRNA-32 inhibits osteosarcoma cell proliferation and invasion by targeting Sox9.

Authors:  Jian-Qiang Xu; Wei-Bin Zhang; Rong Wan; Yao-Qi Yang
Journal:  Tumour Biol       Date:  2014-07-03

6.  MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.

Authors:  Sung-Suk Suh; Ji Young Yoo; Gerard J Nuovo; Young-Jun Jeon; Seokho Kim; Tae Jin Lee; Taewan Kim; Arianna Bakàcs; Hansjuerg Alder; Balveen Kaur; Rami I Aqeilan; Flavia Pichiorri; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

7.  Cytotoxicity of voriconazole on cultured human corneal endothelial cells.

Authors:  Sang Beom Han; Young Joo Shin; Joon Young Hyon; Won Ryang Wee
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

8.  MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells.

Authors:  Xiaomin Dang; Aiqun Ma; Lan Yang; Hao Hu; Bo Zhu; Dong Shang; Tianjun Chen; Yu Luo
Journal:  Cancer Genet       Date:  2012-03

9.  Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle.

Authors:  Hua Tang; Xiao-Yan Tang; Min Liu; Xin Li
Journal:  Clin Chim Acta       Date:  2008-04-24       Impact factor: 3.786

10.  microRNA-32 inhibits the proliferation and invasion of the SGC-7901 gastric cancer cell line in vitro.

Authors:  Jianfeng Zhang; Xiaoling Kuai; Mengjiao Song; Xiaoqi Chen; Zhihua Yu; Hong Zhang; Zhenbiao Mao
Journal:  Oncol Lett       Date:  2013-11-07       Impact factor: 2.967

View more
  26 in total

1.  MK2206 overcomes the resistance of human liver cancer stem cells to sorafenib by inhibition of pAkt and upregulation of pERK.

Authors:  Beibei Zhai; Xiaofeng Zhang; Bin Sun; Lu Cao; Linlin Zhao; Jun Li; Naijian Ge; Lei Chen; Haihua Qian; Zhengfeng Yin
Journal:  Tumour Biol       Date:  2015-12-28

2.  Crosstalk between Meg3 and miR-1297 regulates growth of testicular germ cell tumor through PTEN/PI3K/AKT pathway.

Authors:  Nian-Qin Yang; Xiao-Jin Luo; Jian Zhang; Guo-Min Wang; Jian-Ming Guo
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 3.  The PTEN tumor suppressor gene and its role in lymphoma pathogenesis.

Authors:  Xiaoxiao Wang; Huiqiang Huang; Ken H Young
Journal:  Aging (Albany NY)       Date:  2015-12       Impact factor: 5.682

4.  miR-148a-3p Mediates Notch Signaling to Promote the Differentiation and M1 Activation of Macrophages.

Authors:  Fei Huang; Jun-Long Zhao; Liang Wang; Chun-Chen Gao; Shi-Qian Liang; Dong-Jie An; Jian Bai; Yan Chen; Hua Han; Hong-Yan Qin
Journal:  Front Immunol       Date:  2017-10-16       Impact factor: 7.561

5.  lncRNA MT1JP-overexpression abolishes the silencing of PTEN by miR-32 in hepatocellular carcinoma.

Authors:  Shuhua Zhang; Jianqun Xu; Qing Chen; Fan Zhang; Hongjuan Wang; Hongrong Guo
Journal:  Oncol Lett       Date:  2021-06-15       Impact factor: 2.967

Review 6.  Focus on PTEN Regulation.

Authors:  Miriam Bermúdez Brito; Evangelia Goulielmaki; Evangelia A Papakonstanti
Journal:  Front Oncol       Date:  2015-07-27       Impact factor: 6.244

7.  MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.

Authors:  Chen-Dan Zou; Wei-Ming Zhao; Xiao-Na Wang; Qiang Li; Hui Huang; Wan-Peng Cheng; Jian-Feng Jin; He Zhang; Ming-Juan Wu; Sheng Tai; Chao-Xia Zou; Xu Gao
Journal:  Oncotarget       Date:  2016-01-05

8.  Identification of a Novel lincRNA-p21-miR-181b-PTEN Signaling Cascade in Liver Fibrosis.

Authors:  Fujun Yu; Zhongqiu Lu; Bicheng Chen; Peihong Dong; Jianjian Zheng
Journal:  Mediators Inflamm       Date:  2016-08-16       Impact factor: 4.711

9.  MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma.

Authors:  Wei-Xun Chen; Zhan-Guo Zhang; Ze-Yang Ding; Hui-Fang Liang; Jia Song; Xiao-Long Tan; Jing-Jing Wu; Guang-Zhen Li; Zhuo Zeng; Bi-Xiang Zhang; Xiao-Ping Chen
Journal:  Oncotarget       Date:  2016-04-19

10.  Low Expression of Mir-137 Predicts Poor Prognosis in Cutaneous Melanoma Patients.

Authors:  Nan Li
Journal:  Med Sci Monit       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.